AgeX Therapeutics, Inc. (AGE)

EBITDA Growth

-5.62%

Quarterly · Period ending:

AGE logo

AGE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-5.62%
AGE Quarterly EBITDA YoY % (13.30% → -5.62%)
High-resolution chart · PNG

AGE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. EBITDA Growth — Quarterly
Period endingEBITDA Growth
-5.6204%
5.8824%
-140.0297%
-5,803.75%
-66.1407%
100.1787%
545.4467%
103.4483%
-108.5221%
-341.961%
-98.9143%
-56.7568%
-7.6655%
-2.33%
4.4238%
9.6459%
20.572%
49.2886%
9.8275%
30.1195%
11.5102%
-47.9486%
16.1621%
28.5148%
23.2216%
5.7181%
27.8737%
-59.4844%
-58.2053%
13.2983%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.